Dutch Biotech Event 2024
Hollandbio28/06/24
Join us to celebrate the power of biotech at the Dutch Biotech Event 2024!
About hollandbio’s Dutch Biotech Event
The program features inspiring talks by keynote speakers on biotech and entrepreneurship, followed by workshops and break-out sessions that contribute to your personal development and that of your company. In addition, there will be plenty of opportunities for networking during the break, drinks and BBQ.
Practical information
Date: Friday, June 28th 2024
Time: 12:45 pm – 20:00 pm, including drinks and BBQ
Venue: InnStyle, Herenweg 55 Maarssen
Free parking available. Plan your route.
Program
12:45-13:30 pm – Registration, coffee & tea
13:30-15:10 pm – Plenary program
15:10-16:00 pm – Networking break
16:00-17:00 pm – Break-out sessions
17:00-20:00 pm – Networking drinks & BBQ
Who can join the Dutch Biotech Event?
The Dutch Biotech Event welcomes hollandbio members (registration free of charge) as well as employees of other biotech R&D companies (registration fee €395,- p.p.), with a maximum of 3 delegates per organization.
We invite non-member startups to consider a hollandbio membership, which besides access to the network & events, offers many more advantages.
If you have any questions, please contact hollandbio’s Max to find out more about the options to join the event.
Registration
Registration for the Dutch Biotech Event is now open! Get your tickets here.
Keynote speakers
Peter Rowe – Co-founder & CEO of Deep Branch
Pete is a dynamic entrepreneur spearheading sustainable innovation in food technology. With a background in biotechnology, he is committed to addressing global challenges in food security and environmental sustainability. Deep Branch has pioneered a groundbreaking technology platform, converting carbon dioxide into high-value protein through an innovative fermentation processes. Pete is responsible for the company’s strategy, developing relationships across the company’s value chain and speaking on behalf of the company to a broad range of stakeholders. Pete has been recognised by Forbes Magazine, MIT Technology Review and the Financieele Dagblad as a leading young entrepreneur, due to his dedication and impact to create a more sustainable and resilient food system through biotechnology. Pete’s vision for a future food system centres around technology and innovation drive positive change, enabling nutritious, sustainable, ethical and local food production for everyone.
Sander van Deventer – Co-founder & CEO of VectorY
Sander is a co-founder of VectorY and has 25 years of experience in drug development. He had a critical role in the development of the first commercial monoclonal antibody (Remicade) and the first gene therapy to be granted market authorization in the Western world (Glybera). Sander is also co-founder of Forbion, a leading life science venture capital firm where he is currently an Operating Partner. In 1998 he co-founded Amsterdam Molecular Therapeutics (AMT N.V.), currently uniQure N.V. (NASDAQ: QURE), an AAV-based gene therapy company, acting subsequently as CSO, CMO and CEO. He also served as CEO of Dezima. In 2017, he re-joined uniQure as its part-time CSO where he brought the hemophilia B and Huntington’s disease programs to clinical development. Sander is a former professor of Experimental Medicine and Gastroenterology at the Amsterdam Academic Medical Center and of Translational Gastroenterology at the University of Leiden. He authored over 80 book chapters, 600 peer-reviewed papers, organized international scientific conferences, and supervised more than 40 PhD students. He served on the boards of Hookipa, Engene, Borean, Dezima, Argos, and the scientific advisory boards of Hookipa, Argos, Engene and Staten.
Break-out sessions
Pitch a winning story
Success depends on your ability to pitch a winning story—to raise funding, grow a successful business, and make the world a healthier place. But what is a story, and how do you pitch one that conveys your company’s unique value to investors? In this interactive workshop, you will learn the key principles for turning your complex technology into a winning story and how to apply them to your next pitch. One lucky participant will be selected to pitch their story on stage and receive feedback from pitch coach Giuseppe Marzio, founder and managing director of Chiaro and author of 2022 Amazon bestseller “Winners Have a Story“.
Biotech financing trends: first past the post
What are the current financing trends and tendencies in de biotech investment landscape? Is there any mountain high enough? Are we being send into the woods or drowning at sea? In this session, Robert-Jan van de Vorm, Director Corporate Finance at Van Lanschot Kempen, will take you on a tour on the bumpy road of biotech financing. Gain insights from investors and other biotech entrepreneurs and share your thoughts with our panel of experts consisting of Robert-Jan van der Vorm, Lisanne Blauw (Thuja Capital) and Bas Oosterman (SentryX).
Navigating tomorrow: Leveraging AI for business growth
The AI for Business Growth workshop is designed to introduce the understanding and practical applications of artificial intelligence (AI) in an accessible way. Join this session to gain insights into the potential of AI for their businesses and receive practical tips on how to effectively implement this technology into your own business environment.
Essential basics of biotech board management
What are the key principles and practices of effective governance of your biotech company, or any other innovative organization? During this breakout session, we will dive into the dynamics between management and board, the importance of strategic planning, and the need for effective communication and collaboration: what are the essential basics, knowledge and skills with which you can build and maintain a high-performing board that helps your biotech company thrive?
Made possible by
